Suppr超能文献

一种通过用人甲状腺球蛋白免疫制备的鼠单克隆抗体,与L-甲状腺素和反式三碘-L-甲状腺原氨酸具有同等反应性,并具有独特的个体基因型。

A murine monoclonal antibody derived from the immunization of human thyroglobulin reacts equally with L-thyroxine and reverse triiodo-L-thyronine and has a unique idiotype.

作者信息

Kotani T, Umeki K, Ohtaki S

出版信息

Endocrinol Jpn. 1986 Oct;33(5):629-36. doi: 10.1507/endocrj1954.33.629.

Abstract

Murine monoclonal antibody (mAb 16.3.2) to human thyroglobulin which bound equally to various thyroglobulins derived from nine species was obtained from the fusion of C3H/He spleen cells sensitized with normal human thyroglobulin. Characterization of mAb 16.3.2 revealed that both L-thyroxine (T4) and reverse triiodo-L-thyroxine (rT3) were very efficient in the competitive binding inhibition test and that a molar ratio between T4 and rT3 needed for 50% inhibition of binding to immunized thyroglobulin was about 1:1. Further studies on the idiotype of mAb 16.3.2 using both binding and competitive binding inhibition tests showed that mAb 16.3.2 had a unique idiotype not cross-reacting with other monoclonal antibodies to thyroglobulins. Therefore, a possible explanation offered was that mAb 16.3.2 was endowed with a unique idiotype to be regulated by a distinct idiotype network from those of other mAbs.

摘要

用正常人甲状腺球蛋白致敏的C3H/He脾细胞进行融合,获得了与人甲状腺球蛋白结合的鼠单克隆抗体(mAb 16.3.2),该抗体与来自9个物种的各种甲状腺球蛋白具有同等的结合能力。mAb 16.3.2的特性表明,在竞争性结合抑制试验中,L-甲状腺素(T4)和反式三碘-L-甲状腺原氨酸(rT3)都非常有效,并且50%抑制与免疫甲状腺球蛋白结合所需的T4和rT3摩尔比约为1:1。使用结合和竞争性结合抑制试验对mAb 16.3.2的独特型进行的进一步研究表明,mAb 16.3.2具有独特的独特型,不与其他甲状腺球蛋白单克隆抗体发生交叉反应。因此,给出的一种可能解释是,mAb 16.3.2被赋予了独特的独特型,由与其他单克隆抗体不同的独特型网络进行调节。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验